Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$38.94 - $50.85 $890,635 - $1.16 Million
-22,872 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$37.65 - $63.77 $396,906 - $672,263
10,542 Added 85.5%
22,872 $991,000
Q3 2020

Nov 06, 2020

SELL
$52.76 - $74.49 $5,961 - $8,417
-113 Reduced 0.91%
12,330 $680,000
Q2 2020

Aug 12, 2020

SELL
$48.73 - $81.82 $52,774 - $88,611
-1,083 Reduced 8.01%
12,443 $786,000
Q1 2020

May 11, 2020

SELL
$41.72 - $87.2 $349,530 - $730,561
-8,378 Reduced 38.25%
13,526 $691,000
Q4 2019

Feb 13, 2020

SELL
$45.7 - $81.86 $1.35 Million - $2.42 Million
-29,591 Reduced 57.46%
21,904 $1.74 Million
Q3 2019

Nov 12, 2019

BUY
$45.35 - $57.91 $324,433 - $414,288
7,154 Added 16.13%
51,495 $2.5 Million
Q2 2019

Aug 13, 2019

BUY
$52.6 - $63.29 $317,861 - $382,461
6,043 Added 15.78%
44,341 $2.33 Million
Q1 2019

May 14, 2019

BUY
$39.99 - $53.48 $1.27 Million - $1.7 Million
31,738 Added 483.81%
38,298 $2.03 Million
Q4 2018

Feb 14, 2019

SELL
$31.54 - $46.67 $81,688 - $120,875
-2,590 Reduced 28.31%
6,560 $269,000
Q3 2018

Nov 13, 2018

BUY
$38.0 - $51.1 $19,000 - $25,550
500 Added 5.78%
9,150 $348,000
Q2 2018

Aug 13, 2018

SELL
$38.7 - $50.15 $127,129 - $164,742
-3,285 Reduced 27.52%
8,650 $391,000
Q1 2018

May 15, 2018

BUY
$39.6 - $65.9 $472,626 - $786,516
11,935 New
11,935 $576,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Blair William & CO Portfolio

Follow Blair William & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.